EBMT, ISCT and JACIE experts, with EULAR and ECTRIMS representatives, call for careful patient selection, multidisciplinary care and long-term follow-up as CAR T-cell therapy expands beyond cancer.

The plan sets a clear direction for a scientifically led, digitally enabled and operationally efficient EBMT.